As for the complement system, in a tumor context, it may affect the immunity, angiogenesis, and phenotype of the tumor cells while in terms of immunity, the same complement proteins may influence several immune cells positively or negatively depending on the model or cancer type [32]. The gene discussed is VTN; the disease is cancer.